Latest development in viral vectors for gene therapy

被引:167
作者
Lundstrom, K [1 ]
机构
[1] Regulon Inc BioXtal, CH-1066 Epalinges, Switzerland
关键词
D O I
10.1016/S0167-7799(02)00042-2
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Gene therapy includes the application of various viral vectors, which represent most types and families of viruses, suitable for infection of mammalian host cells. Both hereditary diseases and acquired illnesses, such as cancer, can be targeted. Because of the various properties of each viral vector, the definition of their application range depends on factors such as packaging capacity, host range, cell- or tissue-specific targeting, replication competency, genome integration and duration of transgene expression. Recent engineering of modified viral vectors has contributed to improved gene delivery efficacy.
引用
收藏
页码:117 / 122
页数:6
相关论文
共 44 条
[41]  
Vigna E, 2000, J GENE MED, V2, P308
[42]   Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus [J].
Wilson, SP ;
Yeomans, DC ;
Bender, MA ;
Lu, Y ;
Goins, WF ;
Glorioso, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) :3211-3216
[43]   siRNA-mediated gene silencing in vitro and in vivo [J].
Xia, HB ;
Mao, QW ;
Paulson, HL ;
Davidson, BL .
NATURE BIOTECHNOLOGY, 2002, 20 (10) :1006-1010
[44]   Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12 [J].
Yamanaka, R ;
Zullo, SA ;
Ramsey, J ;
Yajima, N ;
Tsuchiya, N ;
Tanaka, R ;
Blaese, M ;
Xanthopoulos, KG .
JOURNAL OF NEUROSURGERY, 2002, 97 (03) :611-618